Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16.
Enterovirus 71 (EV71) and Coxsackievirus A16 (CVA16) are the two major causative agents of hand, foot and mouth disease (HFMD), for which there are currently no licenced treatments. Here, the acquisition of resistance towards two novel capsid-binding compounds, NLD and ALD, was studied and compared...
Главные авторы: | Kelly, J, De Colibus, L, Elliott, L, Fry, E, Stuart, D, Rowlands, D, Stonehouse, N |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Elsevier
2015
|
Схожие документы
-
Human enterovirus 71 subgenotype B3 lacks coxsackievirus A16-like neurovirulence in mice infection
по: Chan, Y.F., и др.
Опубликовано: (2005) -
Seroprevalence and virologic surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006-2017
по: Kamau, E, и др.
Опубликовано: (2021) -
Neutralization mechanisms of two highly potent antibodies against human enterovirus 71
по: Zhu, L, и др.
Опубликовано: (2018) -
Neutralization mechanisms of two highly potent antibodies against human enterovirus 71
по: Zhu, L, и др.
Опубликовано: (2018) -
Enterovirus A71 and coxsackievirus A16 show different replication kinetics in human neuronal and non-neuronal cell lines
по: Yogarajah, T., и др.
Опубликовано: (2017)